Shumpei Yokota;...; Tadamitsu Kishimoto (2008, Lancet)[Effi cacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial] 理由 免疫サ…